Abuse Liability Associated with Reduced Nicotine Content Tobacco Products (R01)

Funding Opportunity RFA-OD-15-006 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to generate data to inform the FDA on ways to reduce the addictiveness and resulting public health toll from tobacco product use in the United States. Nicotine is the primary constituent responsible for the addictiveness of cigarettes, resulting in smokers inability to quit and continued use. Research addressing nicotine and combusted tobacco product use behaviors (e.g., reinforcing effects, compensation, and amount used) and the dose-effects of nicotine will inform FDA regarding its tobacco regulatory authorities. Research projects must address the research priorities related to the regulatory authority of the Food and Drug Administration (FDA) Center for Tobacco Products (CTP) as mandated by the Family Smoking Prevention and Tobacco Control Act (FSPTCA), Public Law 111-31. The awards under this FOA will be administered by the National Institutes of Health (NIH) using designated funds from the FDA CTP for tobacco regulatory science.
Source: NIH Funding Opportunities (Notices, PA, RFA) - Category: Research Source Type: funding